KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
for
Myasthenia Gravis, Generalized Myasthenia Gravis
Location: Philadelphia PA, Miami FL, Indianapolis IN, Columbia MO,
Sponsor: Kyverna Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06193889
Phase2, Phase3, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase3, Recruiting
Active & Responsive
Transdermal Compress IDE Study
for
Prosthesis and Implants
Location: New York NY, Philidelphia PA, Baltimore MD, Bethesda MD,
Sponsor: Balmoral Medical company
Sex: All
Age: 18 - 60
Code: NCT06134167
Recruiting
Active & Responsive
Pain Outcomes Associated With Exogenous Hormone Therapy in Adults
for
Pain, Gender Minority Individuals
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18 - 50
Code: NCT06939257
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy
for
Obstructive Sleep Apnea, Obstructive Sleep Apnea of Adult
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 18+
Code: NCT06720545
Recruiting
Active & Responsive
Positive Processes and Transition to Health - Single-Session (PATH-SS)